Ongoing quality problems at injectables plant hurt Hospira in Q3
19-Oct-2011 By Gareth Macdonald
Hospira says ‘quality actions’ taken to fix problems at key injectable drug manufacturing plant in US reduced its third quarter earnings.
Icon extends medical imaging capabilities through vRad partnership
19-Oct-2011 By Natalie Morrison
Icon has extended its medical imaging division through a new partnership agreement with Virtual Radiologic (vRad).
JSS & Venn partner to offer transatlantic clinical services
19-Oct-2011
JSS Medical Research has bought Canadian assets from Venn Life Sciences as part of a joint-venture spanning North America and Europe.
New Hamner - PBM venture says its toxicity testing could save billions in drug discovery
19-Oct-2011 By Natalie Morrison
The Hamner Institutes for Health Sciences and private equity firm PBM Capital Group (PBM) have thrashed out a venture for toxicity testing which they say could save the drug discovery industry billions.
GSK hit with warning letter as FDA finds faults with UK site
19-Oct-2011 By Nick Taylor
The FDA has sent GSK a GMP warning letter after finding failings in steps to prevent microbiological contamination at a UK site.
Canadian drug shortage plan fails to tackle problems; analyst
19-Oct-2011 By Nick Taylor
Canadian pharma manufacturers’ plan to stop drug shortages by sharing information fails to tackle underlying concerns, an analyst said.
19-Oct-2011 By Nick Taylor
Gathering data with RFID can ensure reliable pharma packaging supply by improving delivery date predictions, researchers claim.
PPD shares ‘limited’ confidential info with new potential buyer
19-Oct-2011 By Gareth Macdonald
Under offer CRO PPD has signed a confidentiality agreement with another potential buyer according to an SEC filing submitted last week.
Quintiles sets up new clinical research centre in South West England
18-Oct-2011
Quintiles has established a new clinical research centre in the South West of England as part of an expansion of its Prime Site programme.
API and intermediates drive Granules India’s Q2 growth
18-Oct-2011 By Gareth Macdonald
Granules India says higher demand for APIs and pharmaceutical intermediates combined with manufacturing productivity gains helped drive quarterly growth.
Drug delivery devices could be powered by the body, say researchers
18-Oct-2011 By Natalie Morrison
A device developed at the Joseph Fourier University could be used to power drug delivery technologies and medical implants using energy created in vivo within the next decade, say researchers.
CMO Angel & Russian pharma plan drug production JV
18-Oct-2011 By Nick Taylor
Angel Biotechnology is negotiating a joint-venture with a Russian firm that would see it add dedicated production space at a UK site.
Honeywell adds high barrier film for hot & humid climates
18-Oct-2011 By Nick Taylor
Honeywell has introduced a high moisture barrier film to protect sensitive pharmaceuticals in hot and humid climates.
Rusnano and Nearmedic team on nanomedicine manufacturing plant
18-Oct-2011 By Gareth Macdonald
Rusnano and Nearmedic Plus will build a ‘nanomedicine’ production facility in Russia in a collaboration that fits with Government efforts to boost local drug manufacturing.
Lundbeck cuts back on outsourcing in China with new Shanghai R&D centre
18-Oct-2011 By Natalie Morrison
Danish neurodrug developer H Lundbeck is cutting back its Chinese outsourcing after establishing an R&D centre in Shanghai.
Patient recruitment hindered by mistrust of clinical trials
18-Oct-2011 By Nick Taylor
Mistrust of clinical trials and poor patient engagement is limiting recruitment into US studies, an IOM forum heard.
GSK advocates greater supply chain security for trial drugs ahead of 2012 Olympics
18-Oct-2011 By Gareth Macdonald
Securing supply chains and limiting access to manufacturing data can help stop clinical-stage drugs being abused in sport according to UK drug major GSK.
Tech needed to cut rise of fake drugs on Twitter, research says
17-Oct-2011 By Nick Taylor
Spam filtering and identification is needed to stop Twitter becoming another platform for pushers of fake or substandard drugs, researchers say.
Pharma R&D efficiency demands driving discovery services sector, says BASi CEO
17-Oct-2011 By Gareth Macdonald
US CRO Bioanaltyical Systems (BASi) says Big Pharma demand for R&D efficiency is driving growth of outsourced drug discovery services sector.
Movianto building warehouse as logistics growth continues
17-Oct-2011 By Nick Taylor
Movianto is to open a 13,000 sq m pharmaceutical warehouse in the Netherlands as it continues to expand cold-chain capabilities.
Economic reform drove Indian pharma manufacturing boom
17-Oct-2011 By Nick Taylor
Liberalisation of Indian regulations in the early 90s caused a surge in manufacturing capacity but a dip in efficiency, research claims.
17-Oct-2011 By Natalie Morrison
The Chinese Food and Drug Administration (SFDA) plans to ramp up cash rewards for whistleblowers who flag illegal goings on within the Chinese drugs manufacturing sector.
13-Oct-2011 By Nick Taylor
Sproxil and Orange have separately expanded text messaging anti-counterfeiting services in Kenya to tackle fake drugs.
13-Oct-2011 By Gareth Macdonald
Another day, another prediction the contract research sector is set for growth in 2012 with new analysis suggesting ‘mature’ strategic deals and higher demand will drive earnings.
EU Commission may revise guidance on pharma literature
13-Oct-2011 By Natalie Morrison
The EU Commission could soon revise its guidance for information allowed on packaging of prescription-only medicines, after European Parliament urged it to update its original policy.
Execs the winners after tax holiday, Senate report says
13-Oct-2011 By Nick Taylor
A Senate report has slammed the ACRO-backed overseas profit tax break for doing more to help execs’ pay packets than US employment.
AWAC, RecipharmCobra Biologics and O2h rebrand
13-Oct-2011 By Gareth Macdonald
Rebranding seems to be in vougue in the pharmaceutical services sector this month, with three firms changing their monikers.
UNIDO and AUC says Big Pharma can support drugmaking in Africa through partnering
12-Oct-2011 By Gareth Macdonald
The United Nations Industrial Development organisation (UNIDO) says it will help foster pharmaceutical manufacturing in Africa and has called on international Pharmas to do likewise.
Quintiles cuts ribbon on new European headquarters
12-Oct-2011 By Natalie Morrison
Quintiles says it will provide a “seamless” service to its customers through a new European headquarters in Reading, UK.
EPA proposes fine for API plant over waste allegations
12-Oct-2011 By Nick Taylor
The US EPA plans to fine API manufacturer Rhode Technologies for alleged hazardous waste failings at its plant.
Chiltern opens Chicago office
12-Oct-2011
Chiltern has opened a new office in Bannockburn, Chicago.
BASi to relocate in vivo discovery services unit in 2012
12-Oct-2011 By Gareth Macdonald
CRO Bioanalytical Systems (BASi) will move its in vivo discovery services to a new site in West Lafayette, Indiana in 2012 as part over a wider reorganisation of its US operations
FDA releases final guidance on anti-counterfeiting excipients
12-Oct-2011 By Nick Taylor
The FDA has published final guidance on the use of excipients as anti-counterfeiting tools in solid oral dosage forms.
Competitive concerns limit market access outsourcing
12-Oct-2011 By Nick Taylor
Outsourcing of certain market access tasks is limited by concerns that using vendors will give rivals a competitive advantage, a report found.
Parexel and NUS team on clinical research training academy
11-Oct-2011 By Gareth Macdonald
US CRO Parexel has set out to foster clinical research talent in Singapore through a new training academy
CDRD inks affiliation agreement with University of Tokyo's Todai
11-Oct-2011
The Centre for Drug Research and Development (CDRD) and Todai TLO have inked an affiliation agreement to allow joint research projects.
Sanofi Pasteur says it will recoup losses in India with new manufacturing plant
11-Oct-2011 By Natalie Morrison
Sanofi Pasteur says it will regain lost ground in India through its new state-of-the-art vaccine manufacturing plant.
AstraZeneca plans Chinese manufacturing facility to meet local demand
11-Oct-2011 By Natalie Morrison
AstraZeneca has broken ground on a $200m (€147m) manufacturing facility in China to meet soaring demand in the country.
Biologics growth prompts IMB cold-chain distribution guidance
11-Oct-2011 By Nick Taylor
The Irish Medicines Board (IMB) has published guidance for cold-chain storage and transport of APIs and finished products.
Epistem grows as large EU biopharm get collaborative
11-Oct-2011 By Nick Taylor
Collaboration with large European biopharm helped Epistem post double-digit growth in preclinical services sales and operating profit.
Pipeline growth & price rises encouraging signs for CROs
11-Oct-2011 By Nick Taylor
A year-on-year increase in active drug development projects and improving pricing will drive business to CROs, a survey found.
11-Oct-2011 By Gareth Macdonald
The United States Pharmacopeial Convention (USP) has forged closer ties with Russian regulators to help tackle substandard pharmaceuticals and harmonize quality standards.
QCIL expands ARV capabilities in bid to build in East African market
10-Oct-2011 By Natalie Morrison
Ugandan drugs maker Quality Chemical Industries Ltd (QCIL) is ready to manufacture HIV treatment Tenofovir in a bid to dominate the local antiretroviral market.
Aid agency wants Brazil to streamline validation to combat Chagas API shortages
10-Oct-2011 By Gareth Macdonald
Medecins Sans Frontieres (MSF) wants Brazil to streamline its validation process for the API benznidazole after global stocks of the Chagas disease treatment drop to critical levels.
Drug shortages drive demand surge & expansion at Akorn
10-Oct-2011 By Nick Taylor
Akorn is doubling capacity and hiring “as fast as [it] can” after drug shortages sent demand for its injectables soaring.
Encorium seeks partner or PE buyer after loss of biz
10-Oct-2011 By Nick Taylor
Encorium is seeking a CRO partner or private equity buyer after the strategic outsourcing trend hit its revenues and cash reserves.
ACRO backs proposed tax cuts on earnings generated outside US
update
10-Oct-2011 By Gareth Macdonlad
ACRO has backed plans to reduce the tax rate on foreign earnings sent back to the US, arguing that the move would create jobs in the contract research sector.
Vetter opens new US production facility
06-Oct-2011 By Natalie Morrison
Vetter says it will reduce API wastage through its new US production facility for the filling of syringes, cartridges and vials.
Melanoma therapy costs could be slashed thanks to new device, says OncoSec
06-Oct-2011 By Natalie Morrison
The price of melanoma therapy could soon be slashed thanks to a new delivery system developed by US firm OncoSec.
Almac and Greenphire team on automated trial patient payment
update
06-Oct-2011 By Gareth Macdonald
Almac Clinical Technologies has teamed up with Greenphire to create an integrated payment system for study patients that encourages participation.